1. Home
  2. ZJYL vs GBIO Comparison

ZJYL vs GBIO Comparison

Compare ZJYL & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$0.16

Market Cap

32.7M

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.59

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
GBIO
Founded
2006
2016
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
36.3M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
ZJYL
GBIO
Price
$0.16
$5.59
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.88
AVG Volume (30 Days)
1.3M
93.6K
Earning Date
08-20-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$22,826,624.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.19
N/A
Revenue Growth
13.42
N/A
52 Week Low
$0.11
$3.00
52 Week High
$1.03
$9.25

Technical Indicators

Market Signals
Indicator
ZJYL
GBIO
Relative Strength Index (RSI) 39.35 52.25
Support Level $0.12 $5.41
Resistance Level $0.18 $5.72
Average True Range (ATR) 0.03 0.12
MACD -0.00 0.00
Stochastic Oscillator 30.12 66.67

Price Performance

Historical Comparison
ZJYL
GBIO

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: